On the sidelines of the 75th Session of the WHO Regional Committee for Africa in Lusaka, President Hakainde Hichilema addressed the critical issue of equitable access to medicines, vaccines, and new medical technologies. The agenda aims to ensure that all Africans can obtain essential medical supplies.
Vaccines have reduced Zambia’s mortality rate by over 70 percent in the past 25 years. However, the COVID-19 pandemic exposed weaknesses in Africa’s supply chains, with the continent producing only one percent of its vaccine needs. President Hichilema emphasized the importance of external support focused on skills transfer and building local manufacturing capacity. He welcomed backing from partners including Gavi, WHO, and UNITAID through the US$1.2 billion African Manufacturing Accelerator Fund.
In addition, President Hichilema launched the Continental Cholera Response Plan in his role as Global and AU Champion for Cholera. He urged fellow Heads of State to establish Presidential Task Forces to ensure accountability and effective coordination in addressing outbreaks.
The initiatives reflect Zambia’s commitment to strengthening health systems, expanding local production, and protecting public health across Africa. They also highlight the need for regional cooperation to build resilience against future health crises.